Arch Capital Expenditure Coverage Ratio from 2010 to 2024
| ARCH Stock | CAD 1.96 0.04 2.08% |
Capital Expenditure Coverage Ratio | First Reported 2010-12-31 | Previous Quarter (241.45) | Current Value (253.52) | Quarterly Volatility 63.62895248 |
Check Arch Biopartners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arch Biopartners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Total Revenue of 2.4 M or Other Operating Expenses of 6.3 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0 or Days Sales Outstanding of 17.29. Arch financial statements analysis is a perfect complement when working with Arch Biopartners Valuation or Volatility modules.
Arch | Capital Expenditure Coverage Ratio |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arch Stock Analysis
When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.